GBA-Associated Parkinson’s Disease and Other Synucleinopathies

被引：0
|
作者：
Ziv Gan-Or
Christopher Liong
Roy N. Alcalay
机构：
[1] McGill University,Montréal Neurological Institute and Hospital
[2] McGill University,Department of Human Genetics
[3] McGill University,Department of Neurology and Neurosurgery
[4] Columbia University Medical Center,Department of Neurology, College of Physicians and Surgeons
来源：
Current Neurology and Neuroscience Reports | 2018年 / 18卷
关键词：
Parkinson’s disease; Glucocerebrosidase; Genetics; Synucleinopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Involvement of the genes related to lysosomal storage disorders in GBA-associated Parkinson's disease
    Bezrukova, A.
    Bogdanova, D.
    Basharova, K.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Pchelina, S.
    Usenko, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S1 - S2
  • [22] Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients
    Slingerland, Sofie
    van der Zee, Sygrid
    Carli, Giulia
    Slomp, Anne C.
    Boertien, Jeffrey M.
    d'Angremont, Emile
    Bohnen, Nicolaas, I
    Albin, Roger L.
    van Laar, Teus
    BRAIN, 2024, 147 (03) : 900 - 910
  • [23] Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk
    Straniero, Letizia
    Rimoldi, Valeria
    Monfrini, Edoardo
    Bonvegna, Salvatore
    Melistaccio, Giada
    Lake, Julie
    Solda, Giulia
    Aureli, Massimo
    Shankaracharya
    Keagle, Pamela
    Foroud, Tatiana
    Landers, John E.
    Blauwendraat, Cornelis
    Zecchinelli, Anna
    Cilia, Roberto
    Di Fonzo, Alessio
    Pezzoli, Gianni
    Duga, Stefano
    Asselta, Rosanna
    MOVEMENT DISORDERS, 2022, 37 (06) : 1202 - 1210
  • [24] Parkinson's disease and other α-synucleinopathies
    Goedert, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (04) : 308 - 312
  • [25] iPSC-derived in vitro striatal circuits to understand GBA-associated Parkinson's disease
    Do, Quyen
    Ng, Bryan
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 96 - 97
  • [26] Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
    Emelyanov, A. K.
    Baydakova, G. V.
    Andoskin, P. A.
    Nikolaev, M. A.
    Senkevich, K. A.
    Milyukhina, I. V.
    Yakimovskii, A. F.
    Timofeeva, A. A.
    Fedotova, E. Y.
    Nuzhnyi, E. P.
    Illarioshkin, S. N.
    Zakharova, E. Y.
    Pchelina, S. N.
    MOVEMENT DISORDERS, 2016, 31 : S214 - S215
  • [27] Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson's disease
    Kopytova, A.
    Nikolaev, M.
    Senkevich, K.
    Baydakova, G.
    Miliukhina, I.
    Zakharova, E.
    Pchelina, S.
    MOVEMENT DISORDERS, 2019, 34
  • [28] Contribution of the SNCA gene and genes involved in autophagy in the pathogenesis of GBA-associated parkinson's disease
    Basharova, K.
    Bezrukova, A.
    Bogdanova, D.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Emelyanov, A.
    Pchelina, S.
    Usenko, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S11 - S11
  • [29] Cardiovascular autonomic function in GBA-associated Parkinson's disease: a cross-sectional study
    De Santis, T.
    Cocco, A.
    Polverino, P.
    Polvere, V.
    Valente, E. M.
    Albanese, A.
    MOVEMENT DISORDERS, 2023, 38 : S472 - S472
  • [30] Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
    Huh Y.E.
    Park H.
    Chiang M.S.R.
    Tuncali I.
    Liu G.
    Locascio J.J.
    Shirvan J.
    Hutten S.J.
    Rotunno M.S.
    Viel C.
    Shihabuddin L.S.
    Wang B.
    Sardi S.P.
    Scherzer C.R.
    npj Parkinson's Disease, 7 (1)
12345